STOCKWATCH
·
 Medicinal Chemicals and Botanical Products
AGM/EGMMay 6, 2026, 10:01 AM

Philip Morris Holds Annual Meeting; 2025 Net Revenue Over $40B

AI Summary

Philip Morris International (PMI) held its 2026 Annual Meeting of Shareholders, where Group CEO Jacek Olczak highlighted the company's strong performance. Olczak reported that PMI's annual net revenues surpassed $40 billion in 2025, with nearly $17 billion from its smoke-free business, and noted a robust start to 2026. The company aims for best-in-class growth from 2026-2028 and reiterated its commitment to shareholder returns. Shareholders elected 10 director nominees, approved executive compensation, and ratified PricewaterhouseCoopers SA as independent auditors.

Key Highlights

  • Philip Morris International held its 2026 Annual Meeting of Shareholders.
  • 2025 annual net revenues surpassed $40 billion.
  • 2025 smoke-free business net revenues were close to $17 billion.
  • Smoke-free business accounted for 43% of Q1 2026 total net revenues.
  • Company delivered its fifth consecutive year of volume growth in 2025.
  • Shareholders elected 10 director nominees and approved executive compensation.
  • PricewaterhouseCoopers SA was ratified as independent auditors.
  • Approximately 81% of shares entitled to vote were represented at the meeting.
PM
Medicinal Chemicals and Botanical Products
Philip Morris International Inc.

Price Impact